{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T06:58:39Z","timestamp":1772348319607,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T00:00:00Z","timestamp":1269302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00296-010-1415-4","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T05:52:02Z","timestamp":1269237122000},"page":"1045-1049","source":"Crossref","is-referenced-by-count":57,"title":["Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren\u2019s syndrome"],"prefix":"10.1007","volume":"31","author":[{"given":"Sule","family":"Yavuz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Asfuro\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muge","family":"Bicakcigil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebru","family":"Toker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,23]]},"reference":[{"key":"1415_CR1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/B978-012595961-2\/50034-2","volume-title":"The autoimmune diseases","author":"MN Manoussakis","year":"2006","unstructured":"Manoussakis MN, Moutsopoulos HM (2006) Sj\u00f6gren\u2019s syndrome. In: Rose NR, Mackay IR (eds) The autoimmune diseases, 4th edn. Elsevier, St Louis, pp 401\u2013416","edition":"4"},{"issue":"4","key":"1415_CR2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.berh.2006.05.003","volume":"20","author":"PJ Venables","year":"2006","unstructured":"Venables PJ (2006) Management of patients presenting with Sjogren\u2019s syndrome. Best Pract Res Clin Rheumatol 20(4):791\u2013807","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"1415_CR3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/BOR.0b013e328277ef4c","volume":"19","author":"F Mackay","year":"2007","unstructured":"Mackay F, Groom JR, Tangye SG (2007) An important role for B-cell activation factor and B cells in the pathogenesis of Sj\u00f6gren\u2019s syndrome. Curr Opin Rheumatol 19(5):406\u2013413","journal-title":"Curr Opin Rheumatol"},{"key":"1415_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","volume":"109","author":"J Groom","year":"2002","unstructured":"Groom J, Kalled SL, Cutler AH et al (2002) Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren\u2019s syndrome. J Clin Invest 109:59\u201368","journal-title":"J Clin Invest"},{"key":"1415_CR5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","volume":"1050","author":"JO Pers","year":"2005","unstructured":"Pers JO, Daridon C, Devauchelle V et al (2005) BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 1050:34\u201339","journal-title":"Ann N Y Acad Sci"},{"key":"1415_CR6","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.22458","volume":"56","author":"C Daridon","year":"2007","unstructured":"Daridon C, Devauchelle V, Hutin P et al (2007) Abberant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren\u2019s syndrome. Arthritis Rheum 56:1134\u20131144","journal-title":"Arthritis Rheum"},{"key":"1415_CR7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","volume":"62","author":"X Mariette","year":"2003","unstructured":"Mariette X, Roux S, Zhang J et al (2003) The level of BLys (BAFF) correlates with the titre of autoantibodies in human Sjogren\u2019s syndrome. Ann Rheum Dis 62:168\u2013171","journal-title":"Ann Rheum Dis"},{"key":"1415_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/096120339600500108","volume":"5","author":"RI Fox","year":"1996","unstructured":"Fox RI, Dixon R, Guarrasi V, Krubel S (1996) Treatment of primary Sjogren\u2019s syndrome with hydroxychloroquine; a retrospective, open-label study. Lupus 5:31\u201336","journal-title":"Lupus"},{"key":"1415_CR9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/ard.52.5.360","volume":"52","author":"AA Kruize","year":"1993","unstructured":"Kruize AA, Hene RJ, Kallenberg CG et al (1993) Hydroxychloroquine treatment for primary Sjogren\u2019s syndrome; a two year, double blind cross over trial. Ann Rheum Dis 52:60\u201364","journal-title":"Ann Rheum Dis"},{"key":"1415_CR10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Moutsopoulos HM (2002) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American\u2013European consensus group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"1415_CR11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22:640\u2013650","journal-title":"Cornea"},{"issue":"7","key":"1415_CR12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/rheumatology\/kep104","volume":"48","author":"M Rihl","year":"2009","unstructured":"Rihl M, Ulbricht K, Schmidt RE, Witte T (2009) Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren\u2019s syndrome. Rheumatology 48(7):796\u2013799","journal-title":"Rheumatology"},{"key":"1415_CR13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/rheumatology\/keh506","volume":"44","author":"LJ Dawson","year":"2005","unstructured":"Dawson LJ, Caulfield VL, Stanbury JB et al (2005) Hydroxychloroquine therapy in patients with primary Sjogren\u2019s syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase. Rheumatology 44:449\u2013455","journal-title":"Rheumatology"},{"issue":"2","key":"1415_CR14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/ICO.0b013e3181acf68d","volume":"29","author":"E Toker","year":"2010","unstructured":"Toker E, Asfuroglu E (2010) Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy. Cornea 29(2):133\u2013140","journal-title":"Cornea"},{"key":"1415_CR15","first-page":"1356","volume":"41","author":"F Brignole","year":"2000","unstructured":"Brignole F, Pisella PJ, Goldschild M et al (2000) Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 41:1356\u20131363","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1415_CR16","first-page":"2609","volume":"43","author":"ME Stern","year":"2002","unstructured":"Stern ME, Gao J, Schwalb TA et al (2002) Conjunctival T-cell subpopulations in Sj\u00f6gren\u2019s and non-Sj\u00f6gren\u2019s patients with dry eye. Invest Ophthalmol Vis Sci 43:2609\u20132614","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1415_CR17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","volume":"19","author":"SC Pflugfelder","year":"1999","unstructured":"Pflugfelder SC, Jones D, Ji Z et al (1999) Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren\u2019s syndrome keratoconjunctivitis sicca. Curr Eye Res 19:201\u2013211","journal-title":"Curr Eye Res"},{"key":"1415_CR18","first-page":"2283","volume":"42","author":"A Solomon","year":"2001","unstructured":"Solomon A, Dursun D, Liu Z et al (2001) Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry eye disease. Invest Ophthalmol Vis Sci 42:2283\u20132292","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1415_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bjo.85.2.147","volume":"85","author":"VA Smith","year":"2001","unstructured":"Smith VA, Rishmawi H, Hussein H et al (2001) Tear film MMP accumulation and corneal disease. Br J Ophthalmol 85:147\u2013153","journal-title":"Br J Ophthalmol"},{"key":"1415_CR20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2004.05.010","volume":"20","author":"M Thien","year":"2004","unstructured":"Thien M, Phan TG, Gardam S et al (2004) Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20:785\u2013798","journal-title":"Immunity"},{"key":"1415_CR21","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar1912","volume":"8","author":"M Ittah","year":"2006","unstructured":"Ittah M, Micelli-Richard C, Gottenberg JE et al (2006) B cell activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cell in primary Sjogren\u2019s syndrome. Arthritis Res Ther 8:R51","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"1415_CR22","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/ard.2008.095257","volume":"68","author":"S Candon","year":"2009","unstructured":"Candon S, Gottenberg JE, Bengoufa D, Chatenoud L, Mariette X (2009) Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren\u2019s syndrome: correlation with B cell biomarkers and disease activity. Ann Rheum Dis 68(7):1208\u20131212","journal-title":"Ann Rheum Dis"},{"key":"1415_CR23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/bjo.2003.028340","volume":"88","author":"E Toker","year":"2004","unstructured":"Toker E, Yavuz S, Direskeneli H (2004) Anti-Ro\/SSAA and anti-La\/SSB autoantibodies in the tear fluid of patients with Sjogren\u2019s syndrome. Br J Ophthalmol 88:384\u2013387","journal-title":"Br J Ophthalmol"},{"key":"1415_CR24","first-page":"1289","volume":"33","author":"S Yavuz","year":"2006","unstructured":"Yavuz S, Toker E, Bicakcigil M, Mumcu G, Cakir S (2006) Comparative analysis of autoantibodies against \u03b1fodrin in serum, tear fluid, and saliva from patients with Sj\u00f6gren\u2019s Syndrome. J Rheumatol 33:1289\u20131292","journal-title":"J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1415-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-010-1415-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1415-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:18:40Z","timestamp":1559042320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-010-1415-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,23]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1415"],"URL":"https:\/\/doi.org\/10.1007\/s00296-010-1415-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,23]]}}}